SCHEMBL7296011

SCHEMBL7296011

CCOC(=O)C(c1ccc(OC)c(OC)c1)C(C[N+](=O)[O-])c1sccc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
CYP2C19 P33261 1/20 0.55
LMNA P02545 4/20 0.46
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
MAPT P10636 4/20 0.40
NAMPT P43490 1/20 0.36
HTT P42858 3/20 0.36
GAA P10253 3/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
VCP P55072 1/20 0.35
HIF1A Q16665 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7293098 0.85 CA12 (0.43) ALDH1A1CYP2C19LMNACA12CA1
SCHEMBL7304734 0.77 ALDH1A1 (0.54) ALDH1A1CYP2C19LMNACA12CA1
SCHEMBL7303616 0.72 ALDH1A1 (0.59) ALDH1A1CYP2C19LMNACA12CA1
SCHEMBL16231320 0.69 CA12 (0.47) ALDH1A1CYP2C19LMNACA12CA1
SCHEMBL11581308 0.69 CA1 (0.52) ALDH1A1CYP2C19LMNACA12CA1
SCHEMBL29960352 0.68 ALDH1A1 (0.38) ALDH1A1CYP2C19LMNAMAPTGAA
SCHEMBL9380162 0.68 CA12 (0.51) ALDH1A1CYP2C19LMNACA12CA1
SCHEMBL5525324 0.68 ALDH1A1 (0.63) ALDH1A1CYP2C19LMNAMAPTHTT
SCHEMBL5518745 0.68 ALDH1A1 (0.63) ALDH1A1CYP2C19LMNAMAPTHTT
Hydrochloric Acid SCHEMBL11581495 0.68 CA1 (0.51) ALDH1A1CYP2C19LMNACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5444083-A DOPAMINE AGONIST FOR TREATING OR PREVENTION OF HYPERTENSION OR HEART FAILURE EISAI CO., LTD. (JP) 1995-08-22 US disclosed
EP-0381235-B1 PYRROLIDINE COMPOUND AND PHARMACEUTICAL USE Eisai Co., Ltd. (JP) 1993-07-28 EP disclosed
EP-0381235-A2 Pyrrolidine compound and pharmaceutical use Eisai Co., Ltd. (JP) 1990-08-08 EP disclosed